Opko Health, Inc. - stock earnings
OPK Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 1, 2024 BeforeMarket | -0.09 / -0.09 | - | - / 183.0 million | - |
OPK Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -66.5 million USD | 181.9 million USD |
2023Q3 | -84.5 million USD | 178.6 million USD |
2023Q2 | -19.6 million USD | 265.4 million USD |
2023Q1 | -18.2 million USD | 237.6 million USD |
2022Q4 | -85.2 million USD | 185.4 million USD |
2022Q3 | -86.0 million USD | 179.7 million USD |
2022Q2 | -101.4 million USD | 309.9 million USD |
2022Q1 | -55.4 million USD | 329.2 million USD |
2021Q4 | -73.8 million USD | 401.3 million USD |
2021Q3 | 28.7 million USD | 385.8 million USD |
2021Q2 | -16.2 million USD | 442.4 million USD |
2021Q1 | 31.1 million USD | 545.2 million USD |
2020Q4 | 32.3 million USD | 494.6 million USD |
2020Q3 | 23.7 million USD | 428.1 million USD |
2020Q2 | 33.7 million USD | 301.2 million USD |
2020Q1 | -59.1 million USD | 211.5 million USD |
2019Q4 | -112.4 million USD | 224.3 million USD |
2019Q3 | -62.0 million USD | 228.8 million USD |
2019Q2 | -59.8 million USD | 226.4 million USD |
2019Q1 | -80.8 million USD | 222.5 million USD |
2018Q4 | -76.1 million USD | 221.9 million USD |
2018Q3 | -27.7 million USD | 249.8 million USD |
2018Q2 | -6.2 million USD | 263.7 million USD |
2018Q1 | -43.1 million USD | 254.9 million USD |
2017Q4 | -213.9 million USD | 193.7 million USD |
2017Q3 | -46.4 million USD | 263.5 million USD |
2017Q2 | -17.5 million USD | 314.2 million USD |
2017Q1 | -31.0 million USD | 296.1 million USD |
2016Q4 | -13.7 million USD | 275.5 million USD |
2016Q3 | -15.0 million USD | 298.0 million USD |
2016Q2 | 15.5 million USD | 357.1 million USD |
2016Q1 | -12.0 million USD | 291.0 million USD |
2015Q4 | 1.6 million USD | 276.2 million USD |
2015Q3 | 128.2 million USD | 143.0 million USD |
2015Q2 | -42.8 million USD | 42.4 million USD |
2015Q1 | -117.1 million USD | 30.1 million USD |
2014Q4 | -53.0 million USD | 25.5 million USD |
2014Q3 | -48.7 million USD | 19.8 million USD |
2014Q2 | -25.5 million USD | 23.5 million USD |
2014Q1 | -44.6 million USD | 22.3 million USD |
2013Q4 | -16.8 million USD | 20.7 million USD |
2013Q3 | -60.0 million USD | 20.6 million USD |
2013Q2 | -3.4 million USD | 23.8 million USD |
2013Q1 | -34.2 million USD | 31.4 million USD |
2012Q4 | -548000 USD | 16.3 million USD |
2012Q3 | -9.6 million USD | 11.8 million USD |
2012Q2 | -10.2 million USD | 10.2 million USD |
2012Q1 | -8.6 million USD | 8.8 million USD |
2011Q4 | 18.4 million USD | 5.8 million USD |
2011Q3 | -8.2 million USD | 6.8 million USD |
2011Q2 | -5.7 million USD | 10.1 million USD |
2011Q1 | -5.7 million USD | 8.6 million USD |
2010Q4 | -673000 USD | 13.9 million USD |
2010Q3 | -7.4 million USD | 7.6 million USD |
2010Q2 | -6.2 million USD | 7.5 million USD |
2010Q1 | -4.7 million USD | 7.9 million USD |
2009Q4 | -9.1 million USD | 7.0 million USD |
2009Q3 | -6.4 million USD | 1.5 million USD |
2009Q2 | -5.7 million USD | 2.3 million USD |
2009Q1 | -9.0 million USD | 2.3 million USD |
2008Q4 | -9.7 million USD | 1.7 million USD |
2008Q3 | -8.3 million USD | 4.1 million USD |
2008Q2 | -10.9 million USD | 879000 USD |
2008Q1 | -10.9 million USD | 2.8 million USD |
2007Q4 | -9.0 million USD | 847000 USD |
2007Q3 | 1.5 million USD | ? USD |
2007Q2 | -11.0 million USD | ? USD |
2007Q1 | -249.9 million USD | 210000 USD |
2006Q4 | -368000 USD | ? USD |
2006Q3 | -168000 USD | ? USD |
2006Q2 | -68000 USD | ? USD |
2006Q1 | -43000 USD | ? USD |
2005Q4 | -332000 USD | ? USD |
2005Q3 | 871000 USD | ? USD |
2005Q2 | -434000 USD | ? USD |
2005Q1 | -288000 USD | 15000 USD |
2004Q4 | -288000 USD | ? USD |
2004Q3 | -368000 USD | ? USD |
2004Q2 | -531000 USD | ? USD |
2004Q1 | -1.5 million USD | ? USD |
2003Q4 | -1.5 million USD | 13000 USD |
2003Q3 | -1.5 million USD | ? USD |
2003Q2 | -1.8 million USD | 13000 USD |
2003Q1 | -987000 USD | 13000 USD |
2002Q4 | -4.0 million USD | 6000 USD |
2002Q3 | -2.7 million USD | 223000 USD |
2002Q2 | -1.9 million USD | 222000 USD |
2002Q1 | -1.8 million USD | 333000 USD |
2001Q4 | -1.7 million USD | 333000 USD |
2001Q3 | -2.8 million USD | 333000 USD |
2001Q2 | -2.9 million USD | 334000 USD |
2001Q1 | -1.5 million USD | 111000 USD |
2000Q4 | -1.5 million USD | 111000 USD |
2000Q3 | -2.0 million USD | 67000 USD |
2000Q2 | -1.3 million USD | 343000 USD |
2000Q1 | -2.4 million USD | 344000 USD |
1999Q4 | -1.5 million USD | 575000 USD |
1999Q3 | -1.0 million USD | 300000 USD |
1999Q2 | -800000 USD | 300000 USD |
1999Q1 | -1.1 million USD | 200000 USD |
1998Q4 | -800000 USD | 200000 USD |
1998Q3 | -1.0 million USD | 200000 USD |
1998Q2 | -200000 USD | 800000 USD |
1998Q1 | -800000 USD | 100000 USD |
1997Q4 | -800000 USD | ? USD |
1997Q3 | -900000 USD | 100000 USD |
1997Q2 | -800000 USD | 100000 USD |
1997Q1 | -800000 USD | 100000 USD |
1996Q4 | -800000 USD | ? USD |
1996Q3 | -800000 USD | 100000 USD |
1996Q2 | -700000 USD | 100000 USD |
1996Q1 | -700000 USD | 100000 USD |
OPK Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -188.9 million USD | 863.5 million USD |
2022 | -328.0 million USD | 1.0 billion USD |
2021 | -29.5 million USD | 1.8 billion USD |
2020 | 30.6 million USD | 1.4 billion USD |
2019 | -312.0 million USD | 901.9 million USD |
2018 | -153.0 million USD | 990.3 million USD |
2017 | -305.3 million USD | 966.0 million USD |
2016 | -25.1 million USD | 1.2 billion USD |
2015 | -30.0 million USD | 491.7 million USD |
2014 | -171.7 million USD | 91.1 million USD |
2013 | -114.4 million USD | 96.5 million USD |
2012 | -29.0 million USD | 47.0 million USD |
2011 | -1.3 million USD | 28.0 million USD |
2010 | -18.9 million USD | 28.5 million USD |
2009 | -30.1 million USD | 13.1 million USD |
2008 | -39.8 million USD | 9.4 million USD |
2007 | -268.4 million USD | 847000 USD |
2006 | -648000 USD | ? USD |
2005 | -186000 USD | ? USD |
2004 | -1.9 million USD | ? USD |
2003 | -5.8 million USD | 13000 USD |
2002 | -10.4 million USD | 562000 USD |
2001 | -8.8 million USD | 1.3 million USD |
2000 | -7.2 million USD | 865000 USD |
1999 | -4.4 million USD | 1.4 million USD |
1998 | -2.7 million USD | 1.2 million USD |
1997 | -3.3 million USD | 100000 USD |
1996 | -2.9 million USD | 100000 USD |
1995 | -2.7 million USD | 100000 USD |
OPK
Price: $1.27
52 week price:
Earnings Per Share: -0.25 USD
P/E Ratio: -3.71
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 3.2 million
Ebitda: -39.6 millionMarket Capitalization: 857.3 million